Himmler; Gottfried

Patent Applications and Registrations

Patent applications and USPTO patent grants for Himmler; Gottfried.The latest application filed is for "method for engineering immunoglobulins".

Company Profile

8.29.52

Himmler; Gottfried - Gross-Enzersdorf AT
Himmler; Gottfried - Gro -Enzersdorf AT
Himmler; Gottfried - Vienna AT
- Grossenzersdorf AT
Himmler; Gottfried - Grossenzersdorf N/A AT
Himmler; Gottfried - Wien AT
Himmler; Gottfried - A-1180 Vienna AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Engineering Immunoglobulins App 20210388339 - Himmler; Gottfried ; et al.	2021-12-16
Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions Grant 11,084,868 - Himmler , et al. August 10, 2	2021-08-10
Synthetic Immunoglobulin Domains With Binding Properties Engineered In Regions Of The Molecule Different From The Complementarit App 20200079837 - Himmler; Gottfried ; et al.	2020-03-12
Synthetic Immunoglobulin Domains With Binding Properties Engineered In Regions Of The Molecule Different From The Complementarit App 20190382470 - Himmler; Gottfried ; et al.	2019-12-19
Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions Grant 10,385,118 - Himmler , et al. A	2019-08-20
Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies Grant 10,189,905 - Mudde , et al. Ja	2019-01-29
Method Of Producing A Production Cell Line App 20190024114 - Bauer; Anton ; et al.	2019-01-24
Cytotoxic immunoglobulin Grant 10,125,197 - Himmler , et al. November 13, 2	2018-11-13
Secretory immunoglobulin complex Grant 10,059,777 - Himmler August 28, 2	2018-08-28
Novel Multivalent Immunoglobulins App 20180051095 - RUKER; Florian ; et al.	2018-02-22
Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions Grant 9,856,311 - Ruker , et al. January 2, 2	2018-01-02
Method For Engineering Immunoglobulins App 20170369868 - HIMMLER; Gottfried ; et al.	2017-12-28
Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20170334992 - Mudde; Geert ; et al.	2017-11-23
Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20170320943 - Mudde; Geert ; et al.	2017-11-09
Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20170320942 - Mudde; Geert ; et al.	2017-11-09
Display Of Binding Agents App 20170247432 - HIMMLER; Gottfried ; et al.	2017-08-31
Synthetic Immunoglobulin Domains With Binding Properties Engineered In Regions Of The Molecule Different From The Complementarity Determining Regions App 20170204164 - HIMMLER; Gottfried ; et al.	2017-07-20
Display of binding agents Grant 9,651,559 - Himmler , et al. May 16, 2	2017-05-16
Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies Grant 9,636,415 - Mudde , et al. May 2, 2	2017-05-02
Methods For Engineering T-cell Receptors App 20170015727 - Himmler; Gottfried ; et al.	2017-01-19
Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20160362491 - Mudde; Geert ; et al.	2016-12-15
Cytotoxic Immunoglobulin App 20160176984 - Himmler; Gottfried ; et al.	2016-06-23
Cytotoxic immunoglobulin Grant 9,255,149 - Himmler , et al. February 9, 2	2016-02-09
Combination Of Tumor-associated Surface Protein Antigens And Tumor-associated Sugars In The Treatment And Diagnosis Of Cancer App 20160000914 - LOIBNER; Hans ; et al.	2016-01-07
Method For Engineering Immunoglobulins App 20150376603 - Himmler; Gottfried ; et al.	2015-12-31
Secretory Immunoglobulin Deficiency Treatment And Prophlaxis App 20150335738 - Himmler; Gottfried	2015-11-26
Method for engineering immunoglobulins Grant 9,133,274 - Himmler , et al. September 15, 2	2015-09-15
Nanoparticles comprising antigens and adjuvants, and immunogenic structures Grant 9,079,765 - Himmler , et al. July 14, 2	2015-07-14
Cytotoxic Immunoglobulin App 20150166665 - Himmler; Gottfried ; et al.	2015-06-18
Secretory Immunoglobulin Complex App 20150166679 - Himmler; Gottfried	2015-06-18
Display Of Binding Agents App 20150153359 - HIMMLER; Gottfried ; et al.	2015-06-04
Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions Grant 9,045,528 - Ruker , et al. June 2, 2	2015-06-02
Display of binding agents Grant 08921279 -	2014-12-30
Display of binding agents Grant 8,921,279 - Himmler , et al. December 30, 2	2014-12-30
Cytotoxic Immunoglobulin App 20140364592 - Himmler; Gottfried ; et al.	2014-12-11
Cytotoxic immunoglobulin Grant 8,859,738 - Himmler , et al. October 14, 2	2014-10-14
Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20130243767 - Mudde; Geert ; et al.	2013-09-19
Methods For Engineering T-cell Receptors App 20130040836 - Himmler; Gottfried ; et al.	2013-02-14
Method of treating lewis Y-expressing tumors Grant 8,323,650 - Schuster , et al. December 4, 2	2012-12-04
Stabilized Immunoglobulin Constant Domains App 20120094874 - Ruker; Florian ; et al.	2012-04-19
Synthetic Immunoglobulin Domains With Binding Properties Engineered In Regions Of The Molecule Different From The Complementarity Determining Regions App 20120028303 - RUKER; Florian ; et al.	2012-02-02
Synthetic Immunoglobulin Domains With Binding Properties Engineered In Regions Of The Molecule Different From The Complementarity Determining Regions App 20120028839 - RUKER; Florian ; et al.	2012-02-02
LeY SPECIFIC BIOTHERAPEUTIC App 20120010388 - HIMMLER; Gottfried	2012-01-12
Synthetic Immunoglobulin Domains With Binding Properties Engineered In Regions Of The Molecule Different From The Complementarity Determining Regions App 20110251375 - RUKER; Florian ; et al.	2011-10-13
Immunogenic recombinant antibody Grant 8,034,338 - Loibner , et al. October 11, 2	2011-10-11
Cytotoxic Immunoglobulin App 20110046355 - Himmler; Gottfried ; et al.	2011-02-24
N-glycosylated Antibody App 20110020331 - Schuster; Manfred ; et al.	2011-01-27
Immunogenic, Monoclonal Antibody App 20100310551 - LOIBNER; Hans ; et al.	2010-12-09
Display of Binding Agents App 20100184615 - Himmler; Gottfried ; et al.	2010-07-22
N-glycosylated antibody Grant 7,759,464 - Schuster , et al. July 20, 2	2010-07-20
Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20100143342 - Mudde; Geert ; et al.	2010-06-10
Novel Multivalent Immunoglobulins App 20100048877 - Ruker; Florian ; et al.	2010-02-25
Method For Engineering Immunoglobulins App 20100029497 - Himmler; Gottfried ; et al.	2010-02-04
Method For Engineering T-cell Receptors App 20100009863 - Himmler; Gottfried ; et al.	2010-01-14
Use Of A Preparation Based On An Antibody Directed Against A Tumor-associated Glycosylation App 20090181030 - LOIBNER; Hans ; et al.	2009-07-16
Combination Of Tumor-associated Surface Protein Antigens And Tumor-associated Sugars In The Treatment And Diagnosis Of Cancer App 20090130125 - LOIBNER; Hans ; et al.	2009-05-21
Use of a preparation based on an antibody directed against a tumor-associated glycosylation Grant 7,527,789 - Loibner , et al. May 5, 2	2009-05-05
Nanoparticles Comprising Antigens and Adjuvants, and Immunogenic Structures App 20090104268 - Himmler; Gottfried ; et al.	2009-04-23
N-Glycosylated Antibody App 20080095783 - Schuster; Manfred ; et al.	2008-04-24
Immunogenic Recombinant Antibody App 20070258978 - Loibner; Hans ; et al.	2007-11-08
Method for Selecting Epitopes for Immunotherapy App 20070243201 - Loibner; Hans ; et al.	2007-10-18
Immunotherapy of rectal cancer App 20060246056 - Loibner; Hans ; et al.	2006-11-02
Use of antibodies against tumor-associated antigen App 20060127403 - Loibner; Hans ; et al.	2006-06-15
Use of antibodies in a very low dose for the vaccination against cancer App 20060018901 - Loibner; Hans ; et al.	2006-01-26
Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer App 20050255116 - Loibner, Hans ; et al.	2005-11-17
Immunogenic monoclonal antibody App 20050181475 - Loibner, Hans ; et al.	2005-08-18
Use of a vaccine for active immunization against cancer App 20050169929 - Himmler, Gottfried ; et al.	2005-08-04
Use of polyclonal immunoglobulins App 20040151717 - Loibner, Hans ; et al.	2004-08-05
Method for one step isothermal non-transcription based amplification of nucleic acids Grant 6,033,881 - Himmler , et al. March 7, 2	2000-03-07
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,866,694 - Katinger , et al. February 2, 1	1999-02-02
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,756,674 - Katinger , et al. May 26, 1	1998-05-26
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,693,752 - Katinger , et al. December 2, 1	1997-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.